S

Shanghai MicroPort EP Medtech Co Ltd
SSE:688351

Watchlist Manager
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Watchlist
Price: 20.07 CNY -6.3% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Shanghai MicroPort EP Medtech Co Ltd?
Write Note

Shanghai MicroPort EP Medtech Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai MicroPort EP Medtech Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Additional Paid In Capital
ÂĄ724m
CAGR 3-Years
66%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Additional Paid In Capital
ÂĄ2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
40%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Additional Paid In Capital
ÂĄ6.9B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Additional Paid In Capital
ÂĄ711.8m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Additional Paid In Capital
ÂĄ13.9B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort EP Medtech Co Ltd
Glance View

Market Cap
9.4B CNY
Industry
Health Care

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 485 full-time employees. The company went IPO on 2022-08-31. The firm is focused on the fields of electrophysiology intervention treatment and ablation treatment, and it is committed to providing integrated diagnosis and ablation treatment solution with precision intervention navigation at its core. The Company’s main products are heart electrophysiology equipment and related supplies. The firm distributes products both in the domestic market and to overseas markets, including France, Italy, and Spain, among others.

Intrinsic Value
6.42 CNY
Overvaluation 68%
Intrinsic Value
Price
S

See Also

What is Shanghai MicroPort EP Medtech Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.3B CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort EP Medtech Co Ltd's Additional Paid In Capital amounts to 1.3B CNY.

What is Shanghai MicroPort EP Medtech Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
78%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Shanghai MicroPort EP Medtech Co Ltd have been 78% over the past three years .

Back to Top